Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

 

 

Released on: May 10, 2011, 4:29 am
Author: Mark Grayson/ Global Health Progress
Industry: Healthcare

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

To stay informed on the latest news about global investment in pharmaceutical R&D and improving access to medicines, sign up to receive special alerts and newsletters. You can also spread the word about the efforts of the Global Health Progress initiative and keep others informed about how we're affecting change around the world or share your story about how you or someone you know is working to promote global health. Visit the GHP Facebook page or Twitter feeds for the recent news.

Twitter: twitter.com/globalhealth;
Facebook: facebook.com/pages/Global-Health-Progress/124850684219049;
LinkedIn: linkedin.com/groups?home=&gid=2972068

Contact Details: Mark Grayson
950 F Street, NW
Suite 300
Washington, DC 20004
Phone: (202) 835-3460
MGrayson@phrma.org
http://www.globalhealthprogress.org

 

WORD PDF PRINT

Back to previous page
Home page
Submit your press release